Very good job in picking the difference up @reon1, but it is not necessarily a 'smoking gun' in any way.
Recce 327 has always been described as a formulated product comprising a mixtureof oligomers, i.e. this could indicate different 'chain lengths' or repeating units of similar monomers. These could be assemblies of structures that are straight, branched, circular, or having different numbers of functional groups hanging off them. Whatever it is that they are, the description indicates that the product is a mixture of these oligomers. The key to their success at what they do is probably in the composition of the mixture of the parts. So it is no surprise that some of these may be the components that are more responsible for doing the killing of the target organisms than others. So it is quite feasible that the company measures the concentration of the most potent one of these, or the most important in a particular mode of action, as being the best factor to track to define how effective the drug is as a whole. Whatever it was, the results they initially quoted were most pertinent to them even if they were not the same as the unit results we had been thinking in. That does not make them wrong or in error in any way. Unclear to us, yes. What is important is the pile of dead bugs at the end of the process.
- Forums
- ASX - By Stock
- Ann: Clarification - 5x Higher Concentration in Urine & Plasma
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.15%
!
30.5¢

Very good job in picking the difference up @reon1, but it is not...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $54.63K | 174.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 28921 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 0.305 |
4 | 17833 | 0.300 |
2 | 10000 | 0.295 |
11 | 90433 | 0.290 |
2 | 135000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 28921 | 1 |
0.340 | 24538 | 1 |
0.350 | 30000 | 2 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online